Atea Pharmaceuticals, Inc. (AVIR)
NASDAQ: AVIR · Real-Time Price · USD
3.060
-0.440 (-12.57%)
At close: Nov 13, 2025, 4:00 PM EST
3.110
+0.050 (1.63%)
After-hours: Nov 13, 2025, 4:58 PM EST
Atea Pharmaceuticals Market Cap
Atea Pharmaceuticals has a market cap or net worth of $239.07 million as of November 13, 2025. Its market cap has decreased by -17.20% in one year.
Market Cap
239.07M
Enterprise Value
-86.46M
1-Year Change
-17.20%
Ranking
Category
Stock Price
$3.06
Market Cap Chart
Since the IPO on October 30, 2020, Atea Pharmaceuticals's market cap has decreased from $1.94B to $239.07M, a decrease of -87.66%. That is a compound annual growth rate of -33.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 12, 2025 | 277.75M | -1.84% |
| Dec 31, 2024 | 282.95M | 11.19% |
| Dec 29, 2023 | 254.48M | -36.48% |
| Dec 30, 2022 | 400.61M | -46.08% |
| Dec 31, 2021 | 742.94M | -78.48% |
| Dec 31, 2020 | 3.45B | 78.13% |
| Oct 30, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 911.30B |
| Johnson & Johnson | 468.34B |
| AbbVie | 412.21B |
| UnitedHealth Group | 307.13B |
| AstraZeneca | 275.24B |
| Novartis AG | 251.93B |
| Merck & Co. | 226.98B |
| Abbott Laboratories | 224.00B |